Prognostic factors in cancer patients infected with SARS-CoV-2: a Latin American country results

Autor: Erika Ruiz-Garcia, Adriana Peña-Nieves, Jorge Alegria-Baños, Patricia Cornejo-Juarez, Abelardo Meneses-García, Samuel Rivera Rivera, Juan José Sánchez, Raquel Gerson-Cwilich, Daniela Shveid Gerson, Heriberto Medina Franco, Gabriela Alejandra Buerba, Alicia Acosta Espinoza, Norma Valencia Mijares, Edith A. Fernández-Figueroa, Roberto A. Vázquez, Diana Vilar-Compte

Publikováno v: Therapeutic Advances in Chronic Disease, Vol 12 (2021)

Purpose: The aim of this study was to evaluate the demographic characteristics, clinical and pathological factors, and the outcome of cancer and COVID-19 patients in Mexico. Patients and methods: A prospective, multicentric study was performed throug

Externí odkaz: https://doaj.org/article/a3fe4e28761f4e47b96c52bd9c509f1b

Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19

Autor: Ziad, Bakouny, Chris, Labaki, Punita, Grover, Joy, Awosika, Shuchi, Gulati, Chih-Yuan, Hsu, Saif I, Alimohamed, Babar, Bashir, Stephanie, Berg, Mehmet A, Bilen, Daniel, Bowles, Cecilia, Castellano, Aakash, Desai, Arielle, Elkrief, Omar E, Eton, Leslie A, Fecher, Daniel, Flora, Matthew D, Galsky, Margaret E, Gatti-Mays, Alicia, Gesenhues, Michael J, Glover, Dharmesh, Gopalakrishnan, Shilpa, Gupta, Thorvardur R, Halfdanarson, Brandon, Hayes-Lattin, Mohamed, Hendawi, Emily, Hsu, Clara, Hwang, Roman, Jandarov, Chinmay, Jani, Douglas B, Johnson, Monika, Joshi, Hina, Khan, Shaheer A, Khan, Natalie, Knox, Vadim S, Koshkin, Amit A, Kulkarni, Daniel H, Kwon, Sara, Matar, Rana R, McKay, Sanjay, Mishra, Feras A, Moria, Amanda, Nizam, Nora L, Nock, Taylor K, Nonato, Justin, Panasci, Lauren, Pomerantz, Andrew J, Portuguese, Destie, Provenzano, Matthew, Puc, Yuan J, Rao, Terence D, Rhodes, Gregory J, Riely, Jacob J, Ripp, Andrea V, Rivera, Erika, Ruiz-Garcia, Andrew L, Schmidt, Adam J, Schoenfeld, Gary K, Schwartz, Sumit A, Shah, Justin, Shaya, Suki, Subbiah, Lisa M, Tachiki, Matthew D, Tucker, Melissa, Valdez-Reyes, Lisa B, Weissmann, Michael T, Wotman, Elizabeth M, Wulff-Burchfield, Zhuoer, Xie, Yuanchu James, Yang, Michael A, Thompson, Dimpy P, Shah, Jeremy L, Warner, Yu, Shyr, Toni K, Choueiri, Trisha M, Wise-Draper, Catherine, Stratton

Publikováno v: JAMA oncology.

ImportanceCytokine storm due to COVID-19 can cause high morbidity and mortality and may be more common in patients with cancer treated with immunotherapy (IO) due to immune system activation.ObjectiveTo determine the association of baseline immunosup

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::065e94f84a466939ff80f5cd04b003ce
https://pubmed.ncbi.nlm.nih.gov/36326731

Adjuvant Therapy for Stage II Colon Cancer: ASCO Guideline Update

Autor: Nancy N. Baxter, Erin B. Kennedy, Emily Bergsland, Jordan Berlin, Thomas J. George, Sharlene Gill, Philip J. Gold, Alex Hantel, Lee Jones, Christopher Lieu, Najjia Mahmoud, Arden M. Morris, Erika Ruiz-Garcia, Y. Nancy You, Jeffrey A. Meyerhardt

Publikováno v: Journal of Clinical Oncology. 40:892-910

PURPOSE To develop recommendations for adjuvant therapy for patients with resected stage II colon cancer. METHODS ASCO convened an Expert Panel to conduct a systematic review of relevant studies and develop recommendations for clinical practice. RESU

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea79133e4a70c560fdce206176034923
https://doi.org/10.1200/jco.21.02538

1969. SARS-CoV-2 seroprevalence among patients with cancer and healthcare workers from an oncology referral center during the first year of COVID-19 vaccination in Mexico

Autor: Rodrigo Villaseñor-Echavarri, Daniel De-la-Rosa-Martinez, Emmanuel Frias-Jimenez, Alexandra Martin-Onraet, Erika Ruiz-Garcia, Alonso Cruz-Cruz, Luis Alonso Herrera-Montalvo, Diana Vilar-Compte

Publikováno v: Open Forum Infectious Diseases. 9

Background Cancer patients (CPs) with COVID-19 have an increased risk of adverse outcomes. In addition, CPs seem to have a lower immune response to SARS-CoV-2 vaccination. This study aimed to evaluate SARS-CoV-2 spike antibodies (anti-S Abs) followin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8fb4bb58f0a1c858cb04ed8feea712e9
https://doi.org/10.1093/ofid/ofac492.1594

Clinical and prognostic utility of ALBI versus Child-Pugh score in a Mexican population with hepatocellular carcinoma

Autor: Maria del Consuelo Diaz Romero, Stefan Zilli Hernandez, German Calderillo Ruiz, Ana Zyanya Xcaret Camacho Sanchez, Berenice Carbajal, Marytere Herrera, Erika Ruiz-Garcia, Sayako Mariana Miyagui-Adame

Publikováno v: Journal of Clinical Oncology. 41:517-517

517 Background: Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death worldwide. The assessment of liver function is crucial in determining the prognosis of patients. Aim: To compare the utility of the ALBI and CHILD-PUG

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2d8da3a840bee649b244041171969a75
https://doi.org/10.1200/jco.2023.41.4_suppl.517